The nervous system relies on myelin, a protective fatty sheath that surrounds nerve fibers and allows electrical signals to travel quickly between the brain, spinal cord, and body. In dogs affected by SLEM, a genetic mutation disrupts normal myelin formation and maintenance. This leads to a spongy degeneration of nervous tissue, meaning the brain and spinal cord develop microscopic vacuoles (small empty spaces) that interfere with normal neurological function. As the disease progresses, nerve signal transmission becomes increasingly impaired, resulting in severe neurological dysfunction.
Clinical signs of SLEM typically appear early in life, often during puppyhood or young adulthood. Initial symptoms may include weakness, tremors, delayed motor development, and difficulty coordinating movements. Affected puppies may appear unsteady when walking, struggle to stand properly, or show abnormal limb positioning. As the condition progresses, symptoms become more severe and may include pronounced ataxia (loss of coordination), muscle stiffness, hind limb weakness, difficulty walking, and reduced reflexes.
In more advanced stages, dogs may develop significant neurological impairment affecting both mobility and overall quality of life. Some may experience difficulty maintaining balance, inability to walk without assistance, or progressive loss of motor control. In severe cases, the disease can lead to profound disability due to widespread degeneration of white matter in the brain and spinal cord.
The SLEM DNA Health Test is designed to detect the specific genetic mutation responsible for Spongiform Leucoencephalomyelopathy. Testing is simple, safe, and non-invasive, typically performed using a cheek swab or blood sample. The sample is analyzed in a specialized laboratory to determine whether the dog carries zero, one, or two copies of the mutation. Since DNA does not change over a dog’s lifetime, testing can be performed at any age, including in puppies before symptoms appear.
Results are generally reported in three categories:
- Clear (Normal): The dog does not carry the SLEM mutation and cannot pass it to offspring.
- Carrier: The dog carries one copy of the mutation but typically does not show clinical signs. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and is expected to develop neurological signs associated with SLEM.
Genetic testing for SLEM is highly valuable for breeders, veterinarians, and dog owners. Breeders can use test results to make informed decisions that help eliminate the mutation from breeding populations while maintaining healthy genetic diversity. Avoiding carrier-to-carrier mating is essential to prevent affected puppies.
For dog owners, knowing a dog’s genetic status helps ensure early awareness of neurological risk. Although there is currently no cure for SLEM, supportive care such as physiotherapy, mobility assistance, and regular veterinary monitoring may help improve comfort and quality of life in affected dogs.
The Spongiform Leucoencephalomyelopathy (SLEM) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine neurological health, and helps reduce the impact of this rare but severe inherited white matter disorder in future generations.
